Andrew Xilas

Andrew Xilas (chief executive) discloses dealings in STERIS plc to SEC (Form 4). In total, 16 filings cover trades dated from 2 June 2021 to 31 May 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 4 June 2024 with a share grant (€26k) in STERIS plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.